Company Clal Biotechnology Industries Ltd. TEL AVIV STOCK EXCHANGE

CBI

IL0011042806

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sector Other Holding Companies

Inactive Instrument

Clal Biotechnology Industries Ltd (CBI) is an Israel-based biotechnology investment company. CBI's investments are targeted at bio-pharmaceutical companies, which are at different stages of research and development. The Company is a 59%-owned subsidiary of Clal Industries and Investments Ltd. (CII) that is part of IDB group. Clal Biotechnology Industries Ltd. has a number of portfolio companies, namely Andromeda Biotech Ltd., engaged in the field of type 1 diabetes; D-Pharm Ltd and Trombutech, engaged in the field of ischemic stroke; Mediwound Ltd., engaged in burn and wound management; Biokine Ltd, Biocancell Ltd and CureTech, engaged in the field of cancer; Braintact, engaged in the CNS field and Polyheal Ltd, engaged in wound management, among others.

ILS in Million	2021	Weight	2022	Weight	Delta
Investment and Related Activities 100.0 %	132	100.0 %	18	100.0 %	-86.35%

ILS in Million	2021	Weight	2022	Weight	Delta
Israel 100.0 %	132	100.0 %	18	100.0 %	-86.35%

Managers	Title	Age	Since
Assaf Segal CEO	Chief Executive Officer	51	01/15/01
Liat Nissan DFI	Director of Finance/CFO	46	-
Arnon Aharon CTO	Chief Tech/Sci/R&D Officer	55	01/22/01
Jonathan Eilat IRC	Investor Relations Contact	-	-
Joshua Hazenfratz AUD	Comptroller/Controller/Auditor	70	15/07/15
Iris Sadeh AUD	Comptroller/Controller/Auditor	-	01/12/01

Members of the board	Title	Age	Since
Avraham Matityahu Fischer CHM	Chairman	67	09/03/09
Yuval Yanai BRD	Director/Board Member	71	18/15/18
Gad Keren BRD	Director/Board Member	73	17/20/17
Gabriel Barbash BRD	Director/Board Member	74	25/03/25
Tomer Efraim Babai BRD	Director/Board Member	39	05/17/05
Nufar Malovani BRD	Director/Board Member	46	19/17/19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	161,256,549	55,870,242 ( 34.65 %)	4,410,349 ( 2.735 %)	34.65 %

Name	Equities	%	Valuation
Ayalon Mutual Funds Ltd. 0.2400 %	376,433	0.2400 %	42 639 ₪
KSM Mutual Funds Ltd. 0.0749 %	117,475	0.0749 %	13 306 ₪
Migdal Mutual Funds Ltd. 0.0388 %	60,933	0.0388 %	6 902 ₪
Ramco Mutual Funds Management (1989) Ltd. 0.0282 %	44,239	0.0282 %	5 011 ₪
Excellence Nessuah Mutual Funds Management Ltd. 0.0233 %	36,523	0.0233 %	4 137 ₪
Halman Aldubi Mutual Funds Ltd. 0.0105 %	16,543	0.0105 %	1 874 ₪
Menora Mivtachim Mutual Funds Ltd. 0.0102 %	15,995	0.0102 %	1 812 ₪
Edmond de Rothschild Mutual Fund Management Ltd. 0.002755 %	4,321	0.002755 %	489 ₪
U-Bank Mutual Funds Ltd. 0.000427 %	669	0.000427 %	76 ₪

Name	Equities	%	Valuation
GAMIDA CELL LTD. 1.95%	2,581,746	1.95%	92,943 $

Clal Biotechnology Industries Ltd.

Triangle Building Azrieli Center 3

67023, Tel Aviv

http://www.cbi.co.il

address Clal Biotechnology Industries Ltd.(CBI)

Financials

Holding Companies

Holding Companies

Investment Holding Companies

Other Holding Companies

	1st Jan change	Capi.
INVESTOR AB	+16.98%	75.78B
KOÇ HOLDING	+59.45%	17.7B
INVESTMENT AB LATOUR	+2.74%	15.69B
AB INDUSTRIVÄRDEN	+8.60%	14.04B
L E LUNDBERGFÖRETAGEN AB	-0.04%	12.37B
HAL TRUST	+8.96%	11.98B
BAJAJ HOLDINGS & INVESTMENT LIMITED	+5.82%	10.82B
MERITZ FINANCIAL GROUP INC.	+34.35%	10.08B
GROUPE BRUXELLES LAMBERT SA	-1.92%	9.69B

Other Holding Companies